Do Not Disregard

Do Not Disregard When noteworthy past citations are not mentioned in published articles, the disregard syndrome is considered by some to be the result of inadequate literature reviews causing editorial annoyances. It also has been noted to be a serious transgression of bibliographic negligence1 and a menace to honest science.2 Its occurrence as a failure to record previous citations of discovery in the issuing of patents has important legal concerns over ownership of intellectual property

Written byRamon Fusaro
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When noteworthy past citations are not mentioned in published articles, the disregard syndrome is considered by some to be the result of inadequate literature reviews causing editorial annoyances. It also has been noted to be a serious transgression of bibliographic negligence1 and a menace to honest science.2 Its occurrence as a failure to record previous citations of discovery in the issuing of patents has important legal concerns over ownership of intellectual property and economic compensation.

The definition of the disregard syndrome can be conceptually extended to include society's disregard of published paradigm-challenging theories that disrupt society's authoritarian and economic statuses. Society responds to threatening concepts by initiating survival behaviors of either passive obliviousness or active rejection policies that include nonsupport of perceived disruptive research. The disregarding of new ideas has very serious consequences for society in that: (a) the benefits from application of overlooked creative research can be delayed, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies